Address: #11-06 Parkview Square 600 North Bridge Rd Singapore 188778 ,Singapore
Tel: + 65 6299 6880
Hospira is the world’s leading provider of injectable drugs and infusion technologies, backed by proven leadership and more than 70 years’ experience producing high-quality products. Hospira’s breadth of offerings help customers address the safety, productivity and cost of patient care. Used by hospitals worldwide, Hospira products are also prevalent in outpatient clinics and other alternate healthcare sites.
injectable drugs and medical devices
Pfizer Global Established Products’ BU Head and Hospira’s Director of Institutional Affairs tell us about Pfizer’s recent major acquisition of Hospira, their post-merger strategy for increasing market access, as well…
Carolina López-Torres joined Hospira Peru in 2011 following a dynamic career at Novartis. She discusses the early challenges she faced and the opportunities that the government’s hospital expansion plan has…
In 2010, you began your last interview with us by mentioning two things: that because of the nature of this affiliate’s portfolio—with only 35% of revenues generated by pharma at…
Prior to Hospira, you worked for a number of years in several positions at Bayer. What opportunities did you see in moving your career from Bayer to Hospira? During my…
Hospira Mexico is not only the control centre for Central America and Caribbean operations, but it is the Latin American regional office. Why was such importance given to Mexico in…
What is exciting about the Taiwanese market for Hospira today? Hospira is a US-based company, which used to be part of Abbott Laboratories. A major part of the portfolio for…
The Chilean operations for Hospira also manage the Argentine and Uruguayan operations of the company. What led to the decision of choosing Chile as the HQ for the Southern Cone…
Hospira, which was spun-off from Abbott Laboratories in 2004, is a global specialty pharmaceutical and medication delivery company driven by its vision of Advancing Wellness™. Bringing proven leadership and experience,…
Eli Lilly and Company General Manager of South ASEAN, Dr. Faiz Ansari speaks about the expanded scope of his role, Lilly’s pipeline, and the approach that Lilly has taken to…
In an exclusive interview with Alan Ong, Executive Vice President of Asia Pacific and Global Head of Medical Devices and Diagnostics at INC Research, he highlights the current trends facing…
In an exclusive interview with Stephen Ooi, Senior Executive Advisor at Zimmer Biomet, he emphasizes the strategic benefits of the global merger between Zimmer and Biomet and how through leveraging…
In an interview with Takeda’s President of Emerging Markets Business Unit, Giles Platford portrays a vitalized focus on emerging markets and explains why those countries are positioned as one of…
Cerner’s managing director of Southeast Asia, Rebecca LaNasa highlights the key importance that Singapore—as the company’s third office outside the U.S.—serves in implementing and piloting new forms of health care…
Recently appointed Senior Vice President of Asia Pacific, Massimiliano Colella speaks about Smith & Nephew’s reasons for establishing a presence in the region, their dual approach in catering to the…
DB Schenker’s director of healthcare in Asia Pacific, Sugantha Natarajan describes the company’s presence across the region, while emphasizing the crucial need for localized solutions in specialized healthcare logistics. She…
In an exclusive interview with Richard Saynor at GSK, he outlines the growth of the CEP portfolio in emerging markets and highlights the opportunities and challenges in the region, as…
Chin Yau Seng, President of Singapore Airlines Cargo, highlights how SIA Cargo supports Singapore’s reputation as a logistics hub in Asia Pacific and how the carrier has been able to…
Paul Bruhn, Regional Business Head Asia, Oceania, MEA of Nestlé Health Science in Singapore, elaborates on the intricacies of these diverse regions and the strategic importance of Singapore as a…
The founder and CEO of Vela Diagnostics, Michael Tillmann underscores the motivating drivers behind the establishment of the company and how their unique portfolio of automated PCR and NGS solutions…
HGP Partner and Director of Asia, Ming Chua on the company’s reasons for using Singapore as the first point of entry into Asia, while highlighting the expansion of the country’s…
See our Cookie Privacy Policy Here
